DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

Clyde Yancy emphasized that, instead, “there is a benefit to lifestyle modification” in AF.

NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia recurrence…

Continue Reading